Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis
- 67 Downloads
Infective endocarditis (IE) is a rare disease. Although its incidence and bacteriology have remained relatively stable in outpatient populations without injection drug use, health care-associated infections, particularly with staphylococcus, are becoming more common. Large-scale prospective clinical trials are unavailable to guide strategies for preventing IE, timing surgical intervention, and avoiding complications. We continue to rely on new data from smaller series and large observational databases to track these changes and improve care of patients. At the present time, there are several controversies regarding best practices in IE. In this review, we address the following questions: What is the future of recommendations for antibiotic prophylaxis against IE? How should we best use echocardiography in diagnosis, management and follow up of IE patients? What are the most appropriate antibiotic regimens for different patients in the face of shifting microbiology and demographics? Lastly, how should patients be selected for early surgery to avoid the complications of these infections?
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 10.Fowler VG Jr, Miro JM, Hoen B, et al.: Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012–3021. This article presents a very large, international series of patients with definite IE and confirms the increasingly important role of S. aureus as an IE pathogen. It also reviews the contribution of healthcareassociated infections and prevalence of methicillin-resistant S. aureus stratified by region.PubMedCrossRefGoogle Scholar
- 15.Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA: The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983, 5:54–70.PubMedGoogle Scholar
- 28.Baddour LM, Wilson WR, Bayer AS, et al.: Infective endocarditis: diagnosis,antimicrobial therapy,and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology,Stroke,and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:3167–3184. These comprehensive guidelines cover all aspects of IE management. Clinicians who provide care for patients with IE should be familiar with the recommendations, and consultants will want to review them carefully.CrossRefGoogle Scholar
- 36.Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ: Impact of valve surgery on 6-month mortality in adults with complicated,left-sided native valve endocarditis: a propensity analysis. JAMA 2003, 290:3207–3214. This well-done study provides some of the most compelling evidence to date regarding indications for and impact of valve surgery in native valve IE.PubMedCrossRefGoogle Scholar